Zobrazeno 1 - 10
of 161
pro vyhledávání: '"pen injector"'
Autor:
Kahr Rasmussen N, Berg B, Christiansen ASL, Neergaard JS, Ter-Borch G, Hildebrand EA, Gonczi M, Sparre T
Publikováno v:
Patient Preference and Adherence, Vol Volume 18, Pp 1713-1727 (2024)
Niklas Kahr Rasmussen,1 Birgitte Berg,2 Anne Sia Louise Christiansen,3 Jesper Skov Neergaard,1 Gitte Ter-Borch,2 Emily A Hildebrand,4 Maya Gonczi,4 Thomas Sparre1 1Medical & Science Innovation, Novo Nordisk A/S, Søborg, Denmark; 2Clinical Operations
Externí odkaz:
https://doaj.org/article/7a944b446eb241b7ad567dc617046786
Publikováno v:
Medical Devices: Evidence and Research, Vol Volume 17, Pp 271-283 (2024)
Jakob Lange, Andreas E Schneider, Christoph Jordi Ypsomed AG, Burgdorf, SwitzerlandCorrespondence: Jakob Lange, Email Jakob.lange@ypsomed.comBackground: While formative and summative usability testing is essential to confirm safe and effective produc
Externí odkaz:
https://doaj.org/article/444f38d7e4ab4d61a161ab56a76e88ee
Publikováno v:
Фармакоэкономика, Vol 15, Iss 2, Pp 175-186 (2022)
Objective: evaluation of the pharmacoeconomic feasibility of using benralizumab in the form of autoinjector (pen-injector device) in outpatient facilities compared with its use in the form of a syringe in hospital settings for the treatment of severe
Externí odkaz:
https://doaj.org/article/72fcc46ddb5641bcb973d16bbf0fcb4d
Autor:
Bum Chae Choi, Canquan Zhou, Hong Ye, Yun Sun, Ying Zhong, Fei Gong, Ivan Sini, Nadezda Abramova, Salvatore Longobardi, Miranda Hickey, Thomas D’Hooghe
Publikováno v:
Reproductive Biology and Endocrinology, Vol 20, Iss 1, Pp 1-13 (2022)
Abstract Background Ovarian stimulation during medically assisted reproduction treatment should be individualized to optimize outcomes and reduce complications. This study assessed whether use of the recombinant human follicle-stimulating hormone (r-
Externí odkaz:
https://doaj.org/article/b79e2ca0ecf04ff5b04b143c111a9846
Autor:
David C Klonoff, Stephanie Bassock, Andrea Dwyer, Ella Engels, Marianne Qvist, Thomas Sparre, Soren Snitker
Publikováno v:
Journal of Diabetes Investigation, Vol 12, Iss 6, Pp 978-987 (2021)
Abstract Aims/Introduction A single‐dose, shield‐activated pen‐injector for each of the three approved dose variants (0.25, 0.5 and 1 mg) of once‐weekly subcutaneous semaglutide has been developed to improve usability. This analysis presents
Externí odkaz:
https://doaj.org/article/d86c0cbbc2e047d4b48d1fa903110592
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Thomas Weinhold, Marzia Del Zotto, Jessica Rochat, Jessica Schiro, Sylvia Pelayo, Romaric Marcilly
Publikováno v:
AAPS Open, Vol 4, Iss 1, Pp 1-14 (2018)
Abstract Auto-injection devices must be easy and intuitive to use, especially in emergency situations. However, there are many reports of safety-related issues affecting auto-injectors and pen injectors, due to usability deficits. To minimize this ty
Externí odkaz:
https://doaj.org/article/f7bd8966359c4b0784742ec1dbeb9659
Publikováno v:
Medical Devices: Evidence and Research, Vol Volume 11, Pp 105-112 (2018)
Jakob Lange, Tobias Nemeth Ypsomed AG, Burgdorf, Switzerland Background: This article for the first time presents a formative usability study of a fixed-dose pen injector platform device used for the subcutaneous delivery of biopharmaceuticals, prima
Externí odkaz:
https://doaj.org/article/33de18e21414451f9c6d47baff4810d3
Publikováno v:
Акушерство, гинекология и репродукция, Vol 11, Iss 4, Pp 35-42 (2018)
To date, self administrations of recombinant human follicle-stimulating hormone (rhFSH) are carried out using pen injectors with minimal dose increments of 8.33 IU or 12.5 IU (IU – international units of activity). To ensure the accuracy of dose ti
Externí odkaz:
https://doaj.org/article/fd027c159ec74fd8ac130bc3b5f8bb8a